Docking Studies and Biological Evaluation of a Potential β-Secretase Inhibitor of 3-Hydroxyhericenone F from Hericium erinaceus

@inproceedings{Diling2017DockingSA,
  title={Docking Studies and Biological Evaluation of a Potential β-Secretase Inhibitor of 3-Hydroxyhericenone F from Hericium erinaceus},
  author={Chen Diling and Yong Tianqiao and Yang Jian and Zheng Chaoqun and Shuai Ou and Xie Yizhen},
  booktitle={Front. Pharmacol.},
  year={2017}
}
Alzheimer's disease (AD) is the most common neurodegenerative disorder, affecting approximately more than 5% of the population worldwide over the age 65, annually. The incidence of AD is expected to be higher in the next 10 years. AD patients experience poor prognosis and as a consequence new drugs and therapeutic strategies are required in order to improve the clinical responses and outcomes of AD. The purpose of the present study was to screen a certain number of potential compounds from… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 2 times over the past 90 days. VIEW TWEETS
2 Citations
99 References
Similar Papers

References

Publications referenced by this paper.
Showing 1-10 of 99 references

Similar Papers

Loading similar papers…